dabigatran has been researched along with Psoriasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bragazzi, NL; Conic, RRZ; Damiani, G; Finelli, R; Malagoli, P; Morrone, A; Pacifico, A; Pigatto, PDM; Schrom, K | 1 |
| Dickfeld, T; Goldner, R; Schleichert, R | 1 |
2 other study(ies) available for dabigatran and Psoriasis
| Article | Year |
|---|---|
Dabigatran-associated Acute Generalized Exanthematous Pustulosis (AGEP) in a psoriatic patient undergoing Ixekizumab and its pathogenetic mechanism.
Topics: Acute Generalized Exanthematous Pustulosis; Antibodies, Monoclonal, Humanized; Antithrombins; Atrial Fibrillation; Dabigatran; Dermatologic Agents; Humans; Interleukin-17; Male; Middle Aged; Psoriasis; Skin | 2019 |
Palmoplantar pustular eruption due to dabigatran.
Topics: Aged; Antithrombins; Atrial Fibrillation; Biopsy; Dabigatran; Diagnosis, Differential; Drug-Related Side Effects and Adverse Reactions; Eczema, Dyshidrotic; Female; Humans; Psoriasis; Skin; Skin Diseases, Eczematous; Stroke | 2016 |